SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-061610
Filing Date
2021-11-23
Accepted
2021-11-23 16:30:37
Documents
14
Period of Report
2021-11-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea151262-8k_chinapharma.htm   iXBRL 8-K 30144
2 CONVERTIBLE PROMISSORY NOTE DATED NOVEMBER 17, 2021 ea151262ex4-1_chinapharma.htm EX-4.1 91437
3 SECURITIES PURCHASE AGREEMENT BETWEEN CHINA PHARMA HOLDINGS, INC. AND STREETERVI ea151262ex10-1_chinapharma.htm EX-10.1 129649
  Complete submission text file 0001213900-21-061610.txt   485222

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cphi-20211117.xsd EX-101.SCH 3058
5 XBRL LABEL FILE cphi-20211117_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cphi-20211117_pre.xml EX-101.PRE 22381
7 EXTRACTED XBRL INSTANCE DOCUMENT ea151262-8k_chinapharma_htm.xml XML 3600
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 211438914
SIC: 2834 Pharmaceutical Preparations